Narcolepsy with resolution of cataplexy and persisting orexin deficiency.

Wasserman, Danielle; Bassetti, Claudio L. A.; Rosenzweig, Ivana (2020). Narcolepsy with resolution of cataplexy and persisting orexin deficiency. Journal of clinical sleep medicine, 16(8), pp. 1383-1386. American Academy of Sleep Medicine 10.5664/jcsm.8572

Full text not available from this repository. (Request a copy)

None

Narcolepsy type 1 is a debilitating chronic neurological disorder, whose main symptoms of excessive daytime sleepiness and cataplexy may partially improve with time, but typically do not fully resolve. The irreversible loss of orexin neurons is considered to be the pivotal mechanistic link underlying the development of cataplectic attacks in narcolepsy type 1. Here we describe a case of untreated narcolepsy type 1with low cerebrospinal orexin levels (< 50 pg/mL), where cataplexy fully resolved in the first 5-6 years after disease onset, whereas excessive daytime sleepiness persisted.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Bassetti, Claudio

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1550-9389

Publisher:

American Academy of Sleep Medicine

Language:

English

Submitter:

Chantal Kottler

Date Deposited:

12 Nov 2020 16:27

Last Modified:

12 Nov 2020 16:27

Publisher DOI:

10.5664/jcsm.8572

PubMed ID:

32406370

URI:

https://boris.unibe.ch/id/eprint/147396

Actions (login required)

Edit item Edit item
Provide Feedback